Presence of mutation m.14484T>C in a Chinese family with maternally inherited essential hypertension but no expression of LHON

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1822, Issue 10, 2012, Pages 1535-1543

  Guo, Hao ^a,b   Zhuang, Xin Ying ^a   Zhang, A Mei ^a   Zhang, Wen ^a,c   Yuan, Yong ^b   Guo, Li ^b   Yu, Dandan ^a   Liu, Juan ^b   Yang, Da Kuan ^b   Yao, Yong Gang ^a  

^a KUNMING INSTITUTE OF ZOOLOGY   (China)

^b KUNMING MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Arterial stiffness; Chinese; Essential hypertension; LHON; M.14484T>C; MtDNA

Indexed keywords

MITOCHONDRIAL DNA;

ADULT; AGED; ARTERIAL STIFFNESS; ARTERY COMPLIANCE; ARTICLE; BLOOD PRESSURE MONITORING; CHINESE; CLINICAL FEATURE; CONTROLLED STUDY; ELASTICITY; ENVIRONMENTAL FACTOR; ESSENTIAL HYPERTENSION; FEMALE; GENE EXPRESSION; GENE MUTATION; GENETIC LINE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; LEBER HEREDITARY OPTIC NEUROPATHY; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PULSE WAVE; VISUAL ACUITY;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CELL RESPIRATION; DEATH, SUDDEN; DNA, MITOCHONDRIAL; FEMALE; GENOME, MITOCHONDRIAL; HUMANS; HYPERTENSION; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MIDDLE AGED; MUTATION; OPTIC ATROPHY, HEREDITARY, LEBER; REACTIVE OXYGEN SPECIES; VASCULAR STIFFNESS; YOUNG ADULT;

EID: 84864232103     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2012.06.010     Document Type: Article

References (47)

1. He J., Whelton P.K. Epidemiology and prevention of hypertension. Med. Clin. North Am. 1997, 81:1077-1097.
2. Hajjar I., Kotchen J.M., Kotchen T.A. Hypertension: trends in prevalence, incidence, and control. Annu. Rev. Public Health 2006, 27:465-490.
3. Lawes C.M.M., Vander Hoorn S., Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet 2008, 371:1513-1518. International Society of Hypertension.
4. Snieder H., Harshfield G.A., Treiber F.A. Heritability of blood pressure and hemodynamics in African- and European-American youth. Hypertension 2003, 41:1196-1201.
5. Williams R.R., Hunt S.C., Hasstedt S.J., Hopkins P.N., Wu L.L., Berry T.D., Stults B.M., Barlow G.K., Schumacher M.C., Lifton R.P., Lalouel J.M. Are there interactions and relations between genetic and environmental-factors predisposing to high blood-pressure. Hypertension 1991, 18:29-37.
6. Yang Q., Kim S.K., Sun F.Z., Cui J., Larson M.G., Vasan R.S., Levy D., Schwartz F. Maternal influence on blood pressure suggests involvement of mitochondrial DNA in the pathogenesis of hypertension: the Framingham Heart Study. J. Hypertens. 2007, 25:2067-2073.
7. Sun F.Z., Cui J., Gavras H., Schwartz F. A novel class of tests for the detection of mitochondrial DNA-mutation involvement in diseases. Am. J. Hum. Genet. 2003, 72:1515-1526.
8. DeStefano A.L., Gavras H., Heard-Costa N., Bursztyn M., Manolis A., Farrer L.A., Baldwin C.T., Gavras I., Schwartz F. Maternal component in the familial aggregation of hypertension. Clin. Genet. 2001, 60:13-21.
9. Watson B., Khan M.A., Desmond R.A., Bergman S. Mitochondrial DNA mutations in black Americans with hypertension-associated end-stage renal disease. Am. J. Kidney Dis. 2001, 38:529-536.
10. Schwartz F., Duka A., Sun F.Z., Cui J., Manolis A., Gavras H. Mitochondrial genome mutations in hypertensive individuals. Am. J. Hypertens. 2004, 17:629-635.
11. Wilson F.H., Hariri A., Farhi A., Zhao H.Y., Petersen K.F., Toka H.R., Nelson-Williams C., Raja K.M., Kashgarian C.M., Shulman G.I., Scheinman S.J., Lifton R.P. A cluster of metabolic defects caused by mutation in a mitochondrial tRNA. Science 2004, 306:1190-1194.
12. Wang S., Li R., Fettermann A., Li Z., Qian Y., Liu Y., Wang X., Zhou A., Mo J.Q., Yang L., Jiang P., Taschner A., Rossmanith W., Guan M.X. Maternally inherited essential hypertension is associated with the novel 4263A>G mutation in the mitochondrial tRNAIle gene in a large Han Chinese family. Circ. Res. 2011, 108:862-870.
13. Zhu H.Y., Wang S.W., Martin L.J., Liu L., Li Y.H., Chen R., Wang L., Zhang M.L., Benson D.W. The role of mitochondrial genome in essential hypertension in a Chinese Han population. Eur. J. Hum. Genet. 2009, 17:1501-1506.
14. Marian A.J. Mitochondrial genetics and human systemic hypertension. Circ. Res. 2011, 108:784-786.
15. Goto Y., Nonaka I., Horai S. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990, 348:651-653.
16. Maassen J.A., Janssen G.M., 't Hart L.M. Molecular mechanisms of mitochondrial diabetes (MIDD). Ann. Med. 2005, 37:213-221.
17. Tuppen H.A., Blakely E.L., Turnbull D.M., Taylor R.W. Mitochondrial DNA mutations and human disease. Biochim. Biophys. Acta 2010, 1797:113-128.
18. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch. Intern. Med. 1997, 157:2413-2446.
19. Wang H.W., Jia X.Y., Ji Y.L., Kong Q.P., Zhang Q.J., Yao Y.G., Zhang Y.P. Strikingly different penetrance of LHON in two Chinese families with primary mutation G11778A is independent of mtDNA haplogroup background and secondary mutation G13708A. Mutat. Res. 2008, 643:48-53.
20. Ji Y., Zhang A.M., Jia X., Zhang Y.P., Xiao X., Li S., Guo X., Bandelt H.J., Zhang Q., Yao Y.G. Mitochondrial DNA haplogroups M7b1'2 and M8a affect clinical expression of Leber hereditary optic neuropathy in Chinese families with the m.11778G>A mutation. Am. J. Hum. Genet. 2008, 83:760-768.
21. Andrews R.M., Kubacka I., Chinnery P.F., Lightowlers R.N., Turnbull D.M., Howell N. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat. Genet. 1999, 23:147.
22. Gutierrez J., Ballinger S.W., Darley-Usmar V.M., Landar A. Free radicals, mitochondria, and oxidized lipids: the emerging role in signal transduction in vascular cells. Circ. Res. 2006, 99:924-932.
23. Ballinger S.W. Mitochondrial dysfunction in cardiovascular disease. Free Radic. Biol. Med. 2005, 38:1278-1295.
24. O'Rourke M.F., Staessen J.A., Vlachopoulos C., Duprez D., Plante G.E. Clinical applications of arterial stiffness; definitions and reference values. Am. J. Hypertens. 2002, 15:426-444.
25. Lakatta E.G., Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: Aging arteries: a "set up" for vascular disease. Circulation 2003, 107:139-146.
26. Nikoskelainen E.K., Savontaus M.L., Huoponen K., Antila K., Hartiala J. Pre-excitation syndrome in Leber's hereditary optic neuropathy. Lancet 1994, 344:857-858.
27. Mashima Y., Kigasawa K., Hasegawa H., Tani M., Oguchi Y. High incidence of pre-excitation syndrome in Japanese families with Leber's hereditary optic neuropathy. Clin. Genet. 1996, 50:535-537.
28. Sorajja P., Sweeney M.G., Chalmers R., Sachdev B., Syrris P., Hanna M., Wood N.D., McKenna W.J., Elliott P.M. Cardiac abnormalities in patients with Leber's hereditary optic neuropathy. Heart 2003, 89:791-792.
29. Finsterer J., Stollberger C., Prainer C., Hochwarter A. Lone noncompaction in Leber's hereditary optic neuropathy. Acta Cardiol. 2004, 59:187-190.
30. Rose F.C., Bowden A.N., Bowden P.M. The heart in Leber's optic atrophy. Br. J. Ophthalmol. 1970, 54:388-393.
31. Nemes A., De Coo I.F., Spruijt L., Smeets H.J., Chinnery P.F., Soliman O.I., Geleijnse M.L., Ten Cate F.J. Is there alteration in aortic stiffness in Leber hereditary optic neuropathy?. Eur. J. Ophthalmol. 2008, 18:309-312.
32. Fujitake J., Mizuta H., Fujii H., Ishikawa Y., Sasamoto K., Goto Y., Nonaka I., Tatsuoka Y. Leber's hereditary optic neuropathy with intracranial arteriovenous malformation: a case report. Acta Neurol. Belg. 2002, 102:82-86.
33. Tang S., Batra A., Zhang Y., Ebenroth E.S., Huang T. Left ventricular noncompaction is associated with mutations in the mitochondrial genome. Mitochondrion 2010, 10:350-357.
34. Jaksch M., Hofmann S., Kaufhold P., Obermaier-Kusser B., Zierz S., Gerbitz K.D. A novel combination of mitochondrial tRNA and ND1 gene mutations in a syndrome with MELAS, cardiomyopathy, and diabetes mellitus. Hum. Mutat. 1996, 7:358-360.
35. van Oven M., Kayser M. Updated comprehensive phylogenetic tree of global human mitochondrial DNA variation. Hum. Mutat. 2009, 30:E386-E394.
36. Nikoskelainen E.K., Huoponen K., Juvonen V., Lamminen T., Nummelin K., Savontaus M.L. Ophthalmologic findings in Leber hereditary optic neuropathy, with special reference to mtDNA mutations. Ophthalmology 1996, 103:504-514.
37. Yu D., Jia X., Zhang A.M., Li S., Zou Y., Zhang Q., Yao Y.G. Mitochondrial DNA sequence variation and haplogroup distribution in Chinese patients with LHON and m.14484T>C. PLoS One 2010, 5:e13426.
38. Zhang A.M., Jia X., Bi R., Salas A., Li S., Xiao X., Wang P., Guo X., Kong Q.P., Zhang Q., Yao Y.G. Mitochondrial DNA haplogroup background affects LHON, but not suspected LHON, in Chinese patients. PLoS One 2011, 6:e27750.
39. Rachek L.I., Grishko V.I., Ledoux S.P., Wilson G.L. Role of nitric oxide-induced mtDNA damage in mitochondrial dysfunction and apoptosis. Free Radic. Biol. Med. 2006, 40:754-762.
40. Postnov Y.V., Orlov S.N., Budnikov Y.Y., Doroschuk A.D., Postnov A.Y. Mitochondrial energy conversion disturbance with decrease in ATP production as a source of systemic arterial hypertension. Pathophysiology 2007, 14:195-204.
41. Taniyama Y., Griendling K.K. Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 2003, 42:1075-1081.
42. Ballinger S.W., Patterson C., Knight-Lozano C.A., Burow D.L., Conklin C.A., Hu Z., Reuf J., Horaist C., Lebovitz R., Hunter G.C., McIntyre K., Runge M.S. Mitochondrial integrity and function in atherogenesis. Circulation 2002, 106:544-549.
43. Unterluggauer H., Hampel B., Zwerschke W., Jansen-Durr P. Senescence-associated cell death of human endothelial cells: the role of oxidative stress. Exp. Gerontol. 2003, 38:1149-1160.
44. Puddu G.M., Cravero E., Arnone G., Muscari A., Puddu P. Molecular aspects of atherogenesis: new insights and unsolved questions. J. Biomed. Sci. 2005, 12:839-853.
45. Puddu P., Puddu G.M., Cravero E., De Pascalis S., Muscari A. The putative role of mitochondrial dysfunction in hypertension. Clin. Exp. Hypertens. 2007, 29:427-434.
46. Millis R.M. Epigenetics and hypertension. Curr. Hypertens. Rep. 2011, 13:21-28.
47. Turunen M.P., Aavik E., Yla-Herttuala S. Epigenetics and atherosclerosis. Biochim. Biophys. Acta 2009, 1790:886-891.